Found: 11
Select item for more details and to access through your institution.
A Phase II Study of Weekly Docetaxel for Patients with Advanced or Recurrent Cancer of the Cervix.
- Published in:
- Gynecologic & Obstetric Investigation, 2007, v. 64, n. 4, p. 193, doi. 10.1159/000106489
- By:
- Publication type:
- Article
Endometrial cancer: treatment of nodal metastases.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma(The following member institutions participated in the current study: Abington Memorial Hospital (Abington, Pennsylvania); Colorado Gynecologic Oncology Group P.C. (Denver, Colorado); University of CaliforniaLos Angeles (Los Angeles, California); University of Pennsylvania Cancer Center (Philadelphia, Pennsylvania); University of North Carolina School of Medicine (Chapel Hill, North Carolina); University of Iowa Hospitals and Clinics (Iowa City, Iowa); University of Texas Southwestern Medical Center at Dallas (Dallas, Texas); Indiana University Medical Center (Indianapolis, Indiana); Wake Forest University School of Medicine (Winston-Salem, North Carolina); State University of New York at Stony Brook (Stony Brook, New York); Cooper Hospital/University Medical Center (Camden, New Jersey); Columbus Cancer Council (Columbus, Ohio); Fox Chase Cancer Center)
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 8, p. 1664, doi. 10.1002/cncr.11690
- By:
- Publication type:
- Article
A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.
- Published in:
- Genes, Chromosomes & Cancer, 2010, v. 49, n. 9, p. 791, doi. 10.1002/gcc.20782
- By:
- Publication type:
- Article
Does the Progression-Free Interval After Primary Chemotherapy Predict Survival After Salvage Chemotherapy in Advanced and Recurrent Endometrial Cancer?
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 23, p. 5407, doi. 10.1002/cncr.25480
- By:
- Publication type:
- Article
Ultra-Early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 4, p. 903, doi. 10.1002/cncr.24822
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for the "Oldest Old" Ovarian Cancer Patients: Can We Anticipate Toxicity-related Treatment Failure in a Vulnerable Population?
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 7, p. 1472, doi. 10.1002/cncr.24190
- By:
- Publication type:
- Article
Ovarian cancer metastatic to the brain: What is the optimal management?
- Published in:
- Journal of Surgical Oncology, 2001, v. 78, n. 3, p. 194, doi. 10.1002/jso.1149
- By:
- Publication type:
- Article
Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents.
- Published in:
- Oncologist, 2010, v. 15, n. 10, p. 1026, doi. 10.1634/theoncologist.2010-0087
- By:
- Publication type:
- Article
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article